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ABSTRACT  Cell extracts and conditioned media (CM) from cultured bovine aortic endothelial 
cells (BAEs) were fractionated by PAGE in the presence SDS, and plasminogen activator (PA) 
activity was  localized  by  fibrin  autography.  Multiple  molecular weight  forms  of  PA  were 
detected in both preparations. Cell-associated PAs had Mr of 48,000, 74,000, and 100,000 while 
secreted PAs showed Mr of 52,000, 74,000, and 100,000. A  broad zone of activity (Mr 80,000- 
100,000) also was present in both cellular fractions. In addition, PAs of  Mr 41,000 and 30,000 
appeared upon prolonged incubation or repeated freezing and thawing of the samples, and 
probably represent degradation products of higher molecular weight forms. This complex lysis 
pattern was not observed when CM was subjected to isoelectric focusing. Instead, only two 
classes of activator were resolved, one at pH 8.5, the other at 7.6. Analysis of focused samples 
by SDS PAGE revealed that the activity at pH 8.5 resulted exclusively from the Mr 52,000 form; 
all other forms were recovered at pH 7.6. The activity of the Mr 52,000 form was neutralized by 
anti-urokinase IgG  but  was  not  affected  by  antitissue activator  IgG  indicating that  it  is  a 
urokinaselike PA.  The  activities of  the  Mr  74,000-100,000  forms  were  not  affected  by  anti- 
urokinase. They were blocked by antitissue activator suggesting that all the forms in this group 
were tissue-type PAs. The multiple forms of PA were differentially sensitive to inactivation by 
diisopropylfluorophosphate (DFP).  Treatment of CM  with  10 mM  DFP for 2 h  at 37°C only 
partially inhibited the 52,000-dalton form. However, it completely inactivated the 74,000-dalton 
PA. The activity of the Mr 100,000 form was not affected by this treatment, or by treatment with 
40  mM  DFP. Thus, cultured  BAEs produce  multiple,  immunologically distinct forms  of  PA 
which differ in size, charge, and sensitivity to DFP. These forms include both urokinaselike and 
tissue-activator-like PAs. The possibility that one of these forms is a zymogen is discussed. 
Plasminogen activator (PAs) convert the zymogen plasminogen 
into its  proteolytically active form, plasmin  (1).  PAs are ex- 
tremely specific serine proteinases found in a variety of ceils, 
tissues,  and body fluids (2, 3). They have been classified into 
two immunologically distinct groups, those that are neutralized 
by anti-urokinase antibodies (urokinaselike) and those that are 
neutralized by antitissue activator antibodies (tissue activator- 
like) (4). No cross reactivity has been reported between the two 
activator groups. Although these molecules activate plasmino- 
gen  by  cleavage  of the  same  arginine-valine  bond  (5),  the 
mechanism of activation differs considerably. Tissue activator, 
unlike urokinase, requires a cofactor before its PA activity can 
be expressed (6). Interestingly, this cofactor appears to be fibrin 
itself (7). 
The plasma fibrinolytic system is responsible for the disso- 
lution of blood clots, and thus promotes continued circulation 
of blood through an unobstructed vascular bed. Unfortunately, 
the origin and characteristics  of the PA in blood responsible 
for initiating and controlling this process remain unclear (5). 
The  fibrin-dependency  of tissue  activators  and  their  fibrin- 
binding properties guarantee their accumulation and activation 
on the  surface of fibrin clots.  These characteristics,  together 
with the recent findings that these molecules are both efficient 
and specific thrombolytic agents (8) suggest that tissue activa- 
tor,  not  urokinase,  is  the  physiologically  relevant  vascular 
activator.  We  have  begun  to  study  the  PAs  produced  by 
cultured endothelial cells since available information suggests 
that the vascular activator may originate from the endothelium 
itself (9,  10). Here we show that bovine aortic endothelial cells 
(BAEs) produce multiple molecular weight forms of PA; these 
forms include both urokinaselike and tissue-activator-like mol- 
ecules. 
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Cell Culture 
BAEs were isolated from the aortae of freshly killed cows by the method of 
Booyse et al. (11 ) and cultured as indicated (12). The cells used for most of these 
studies had been passaged 5 to 20 times and were positive for Factor VIII antigen. 
Cloned BAEs were used in some experiments. One clone was isolated in our 
laboratory from a  single cell that grew out of a primary cell preparation from 
bovine aorta. Four clones were isolated and kindly provided by Drs. C. Gajdusek 
and S.  Schwartz (13),  and the 6th clone was the generous gift of Dr. W.  Laug 
(14). All cultures were grown to confluency in 60-mm dishes before use (15). 
Preparation and Treatment of Cell Extracts and 
Conditioned Medium (CM) 
To prepare cellular extracts, cultures were washed twice with cold phosphate 
buffered saline (PBS) (0.14 M NaCI, 0.01 M sodium phosphate, pH 7.2), extracted 
with 250 #1 of Triton X-100 (0.5% vol/vol in PBS; Sigma Chemical Co., St. Louis, 
MO) and removed with a rubber policeman. The culture dish was washed once 
with 750 gl PBS,  and the extract and wash were pooled. All samples were used 
immediately after preparation. Conditioned media was prepared by incubating 
washed  monolayers  in  serum-free  MEM  for  24  h.  This  CM  was  collected, 
centrifuged at 1,000 g to remove cellular debris and stored in 0.5% Triton X-100 
at -30°C until used. 
Inactivation studies with diisopropylfluorophosphate (DFP; Sigma Chemical 
Co.),  were performed with Triton X-100-released cellular PA and with CM (in 
0.2 M sodium phosphate, pH 7.2).  Samples were treated with 1 mM or l0 mM 
DFP at 37°C. At 30 rain, I h, and 2 h, 100-/d aliquots were removed and quickly 
frozen in an ethanol dry ice bath. Samples were fractionated by SDS PAGE and 
analyzed for  PA activity on fibrin-agar gels (fibrin autography).  To  prepare 
Triton X-100-released PA, cultures were washed twice with cold PBS,  scraped 
into 1 ml of homogenization buffer (0A  M Tris-HCl, pH 7.4, 0.25 M sucrose, 1 
mM  EDTA)  and homogenized until 90--95% of the cells were disrupted. The 
nuclei were removed by centrifugation at 600 g for 10 rain and then the membrane 
fraction was isolated by centrifugation for 90 rain at 100,000 g. This microsomal 
pellet was rasuspended in 0.5 ml of 0.1 M sodium phosphate, pH 7.2, an equal 
amount of Triton X-100 (wt/wt) was added, and tbe residual particulate matter 
was removed by centrifugation at 100,000 g for 90 rain. This treatment resulted 
in the release of 85-95% of the PA activily from the membrane fraction. 
PAGE 
SDS  polyacrylamide slab gels and buffers were prepared as described by 
Laemmli (16)  with resolving gels of 9% acrylamide and stacking gels of 4% 
acrylamide. Samples were applied to the gels and subjected to electrophoresis at 
40 V at room temperature. Molecular weight standards included human trans- 
ferrin (76,000), human serum albumin (65,000), ovalbumin (43,000), chymotryp- 
sinogen (25,700),  and soybean trypsin inhibitor (16,700).  Portions  of the  gel 
containing these  standards  were  removed  and  stained  for  30  min  with  1% 
Coomassie Blue and 50% trichloroacetic acid, and then destained in 10% acetic 
acid. The remaining portion of the gel was processed for fibrin autograpliy to 
localize PA activity. 
Fibrin Autography 
To prepare fibrin agar indicator gels (17),  a  2% solution of agarose (LPG 
agarose, Miles Laboratories, Elkhardt, IN) in water was boiled, cooled to 47°C 
and  mixed with  prewarmed  PBS  containing plasminogen (19.5  /tg/ml)  and 
thrombin (0.6  U/ml). Fibrinogen (10 mg/ml) in PBS  (37°C) was added,  the 
solution was mixed rapidly and poured on a glass plate. Final concentrations 
were  1% agarose, 5.8 t*g/ml plasminogen, 0.18  U/ml thrombin, and 2  mg/ml 
fibrinogen. The fibrin-agar gel was used immediately. After electrophorasis, the 
SDS gels were soaked in 2.5% Tiiton X-100 for 1.5 h to remove the SDS, patted 
dry with a paper towel, and applied to the surface of the fibrin-agar indicator gel. 
The indicator gel was allowed to develop at 37°C in a moist chamber, and then 
photographed. The dark areas of the indicator gel correspond to the lyric zones 
initiated by the interaction of PA in the SDS gel and plasminogen in the indicator 
gel. No lyric zones were detected in the indicator gel in the absence of plasmin- 
ogen. 
Activity neutralization studies were performed by incorporating rabbit anti- 
urokinase IgG (20 gg/ml) or rabbit antitissue activator IgG (10 #g/ml) into the 
fibrin-agar indicator gel mixture. A  9%  SDS  gel containing various PAs was 
placed on the antibody containing indicator gel and incubated at 37°C. Control 
fibrin agar plates containing normal rabbit IgG at the same concentrations were 
also tested. 
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Isoelectric  Focusing and Two Dimensional 
Gel Electrophoresis 
Iso~lectric focusing of CM  was performed in 5% polyacrylamide slab gels 
containing 6M urea (ultra pure, Schwartz-Mann, Orangeburg, NY), 0.5% Triton 
X-100,  10% glycerol, and 5% ampholytes (pH 3.5-10,  8-9.5,  9  11  in a  ratio of 
5:2:1; LKB Instruments, Inc., Rockville, MD). Conditioned media was dialyzed 
overnight in 0.5% Triton X-100, 6M urea to remove ions before application. The 
gels were electrofocused on an LKB  multiphor system at  15 W  for 3  h  using 
electrode solutions of 1 M  NaOH and  I  M  H3PO4. After electrofocusing was 
completed, one lane was removed from the slab gel, sliced into 0.5-cm slices, and 
each slice was then soaked in 0.5 ml of 0.5% Triton X-100 for 30 min and the pH 
determined. The slices were allowed to continue soaking overnight and an aliquot 
assayed for PA activity on 12:'I-fibrin plates. Focused samples were also analyzed 
by SDS PAGE (2-dimensional  gel electrophoresis). A duplicate lane was removed 
from the focusing gel and soaked for 60 min. in 0.05 M Tris-HC1 pH 8, containing 
10% glycerol, 0.025% bromphenol blue, and I% SDS. It was then placed on top 
of an SDS gel and subjected to fractionation by SDS PAGE as described above. 
PA activity was localized by fibrin autography. 
Assay of Fibrinolytic Activity 
PA activity was assayed on ~2'~i-fibrin coated mulliwell tissue culture dishes 
(24 wells, 16 mm; Costar Data Packaging, Cambridge, MA) as described (15). 
The standard cell-free assay contained in 1 ml: 4/Lg human plasminogen, 0.1% 
gelatin, 0.1  M  Tris-HC1,  pH  8.1,  and  a  source of PA.  Fibrinolysis was not 
observed  when  plasminogen or  PA  was omitted from  the  reaction  mixture, 
indicating that hydrolysis of the 12'~I-fibrm  resulted from conversion of plasmin- 
ogen into plasmin by PA. 
Immunochemistry 
Rabbit antiserum raised against human urokinase was a gift from Collabora- 
tive Research, Waltham, MA. To prepare IgG fractions, antiserum or nonimmune 
serum was combined with an equal volume of 0.15  M  sodium chloride, and 
ammonium sulfate was added slowly to 45% saturation. This solution was stirred 
for 15 min and centrifuged at 20,000 g for 20 min. The pellet was resuspended in 
0.15 M  sodium chloride and the ammonium sulfate fractionation repeated two 
more times. The final precipitate was redissolved and dialyzed extensively  against 
0.07  M potassium phosphate, pH 7.2, and then chromatographed on a DEAE- 
cellulose column equilibrated in the  same  buffer.  The  unbound  protein was 
collected, dialyzed against PBS and concentrated to 2 mg/ml of IgG. The rabbit 
antihuman  tissue activator IgG  (2  mg/ml)  was isolated by adsorption  onto 
Protein A-Sepharose columns as described (4) and was a generous gift from Dr. 
D. Collen, University of Leuven, Leuven, Belgium. 
Miscellaneous 
Protein was determined by the method of Bradford (18)  using bovine serum 
albumin as a standard. Radioactivity measurements of 12Sl were performed in a 
Micromedic gamma spectrometer (Micromedic Systems, Horsham,  PA).  Plas- 
minogen was prepared by affinity chromatography on lysine-Sepharose as de- 
scribed  (19).  Bovine  fibrinogen  fraction  1  (CalBiochem-Behring Corp.,  San 
Diego, CA) was purified free of plasminogen by ethanol precipitation in the 
presence of lysine (20). Human a-thrombin was a generous gift from Dr. Fenton 
(Albany, NY). Purified human urokinase (W.H.O.  Standard) was supplied by 
Dr. A. Johnson, New York University. Human tissue plasminogen activator was 
purified from cultured melanoma cells and was a gift from Dr. D. Collen (21). 
RESULTS 
Fractionation  of Cellular PAs by SDS PAGE 
Cell extract and CM were fractionated by SDS PAGE and 
PA activity was localized by the development of lyric zones on 
fibrin indicator plates (Fig.  1).  After 4  h  of incubation,  lysis 
zones corresponding to Mr of 48,000  in cell extracts  (lane  1) 
and  52,000  and  74,000  in  CM  (lane  2)  were  apparent.  The 
fractionation  and  analysis  of urinary  PA  (urokinase)  of Mr 
55,000 and 33,000 is shown in lane 3 for comparative purposes. 
Upon prolonged incubation  of the cellular samples (8 h),  an 
additional zone at Mr 74,000 appeared in the cell extract sample 
(lane 4), while one at Mr 100,000 appeared in the lane contain- 
ing  CM  (lane  5).  Cell  extract  also  contained  material  at  Mr 100,000 but its detection required a longer incubation time (not 
shown). Characteristically,  lysis was also observed in the area 
between the 74,000- and 100,000-dalton PAs but it appeared as 
an unresolved smear rather than as distinct bands (lanes 4 and 
5). In a few preparations,  additional forms of PA with molec- 
ular  weights  of 51,000  (extract)  and  55,000  (CM)  were  also 
detected, although conditions under which they were generated 
have  not  been  established.  No  activity was  observed  in the 
absence of  plasminogen. These complex lysis patterns were not 
altered when samples were prepared in the presence of soybean 
trypsin inhibitor (50/~g/ml) and analyzed in the presence of 8 
M  urea  (not shown).  However, prolonged incubation  of cell 
extract or CM at 37 °C, or repeated freezing and thawing of the 
samples generated PAs of Mr 41,000 and 30,000.  These forms 
are probably degradation products of higher molecular weight 
forms. The molecular weights of the various cell associated and 
secreted PAs are summarized in Table I. Similar results were 
obtained when CM and extract from cloned BAEs was ana- 
lyzed by these techniques (unpublished observation). 
fractionation  of Cellular  PAs  by 
Isoelectric  Focusing 
The isoelectric points (pI) of the various forms of PA in CM 
were determined (Fig. 2). Dialyzed CM was electrofocused as 
indicated. The gel was sliced into 5-mm sections and each slice 
was  then  tested  for fibrinolytic  activity on  ~25I-fibrm coated 
dishes.  Two areas of activity were observed. The most active 
material accumulated between pH 8.4-8.6 with the peak at pH 
8.5  (Fig. 2A).  The less active material  corresponded to a  pI 
FIGURE  1  Fibrin autographs showing cell  associated and secreted 
PAs  fractionated  by  SDS  PAGE.  Conditioned  media  (100/d),  cell 
extract  (150 gg),  and  urokinase (0.5  U)  were fractionated by SDS 
PAGE  and  PA activity  localized on fibrin-agar gels. The dark areas 
correspond to fibrin lysis zones. Cell extract (lanes I, 4); CM (lanes 
2, 5); urokinase (lane 3). Lanes I-3 were allowed to develop for 4 h, 
Lanes 4-5 for 8 h. 
TABLE  I 
Properties of Plasminogen Activators Produced by Bovine 
Aortic Endothelial Cells 
Cell-associated  Secreted 
Mr  Mr  pl 
48,000  4- 2,900  52,000 +  2,200  8.5 
74,600 +-- 2,000  74,000 4- 4,600  7.6 
80,000-  100,000  80,000-  100,000  7.6 
I00,000 +_ 2,900  I00,000 +  3,300  7.6 
Cell extract and CM were fractionated  by SDS PAGE and PA activity  localized 
on a fibrin-agar  gel. Molecular weights are an average of at least five deter- 
minations. The pls are calculated from experiments similar to those shown in 
Fig. 2 and are the result of two separate determinations. 
FIGURE  2  Analysis of cellular  PAs  by  isoelectric focusing.  Condi- 
tioned  media  was electrofocused on  a  5%  acrylamide slab gel  as 
indicated in Materials and Methods. Lanes parallel to the direction 
of migration were cut out of the gel and treated as follows: (A) The 
gel strip was cut into 0.5-cm slices,  each slice was then incubated in 
0.5  ml  of 0.5% Triton X-100 for 30 min  at which  time the pH of the 
sample was determined (C)  O). Incubation was continued for 16 
h  at 4°C to allow PA to diffuse out of the gel slice. The PA activity 
of these samples was determined  (H).  (B)  A  duplicate  lane 
from the isoelectric focusing gel was subjected to further fraction- 
ation by SDS PAGE. PA activity was localized by fibrin autography. 
The separate lane at the  left shows CM  fractionated only  by SDS 
PAGE. 
value of 7.4-7.8, with the peak of activity at pH 7.6. To relate 
these isoelectric forms to the molecular weight forms shown in 
Fig.  1, focused samples were subjected to additional fraction- 
ation by SDS PAGE (Fig. 2B). The PA form ofpI 8.5 consisted 
of a single molecular species of Mr 52,000.  Unexpectedly, the 
smaller  peak  of activity  (pI  7.5)  contained  all  the  higher 
molecular weight  forms (Mr  74,000-100,000).  The pI of the 
various molecular weight forms of activator are summarized in 
Table I. 
Immunological  Characterization  of Cellular PAs 
Urokinase  and  tissue  activator were  fractionated  by  SDS 
PAGE  and  then  analyzed  by  fibrin  autography.  The  fibrin 
indicator gels contained either anti-urokinase IgG or antitissue 
activator lgG. Nonimmune IgG was added to parallel  fibrin 
indicator gels as controls. The presence of antitissue activator 
IgG blocked the development of tissue activator initiated lytic 
zones (Fig. 3) but did not affect the activity of purified uroki- 
nase.  Conversely, the presence of antiurokinase  IgG neutral- 
ized  urokinase  activity  but  was  not  effective  against  tissue 
activator. The activities of the multiple cellular PA forms also 
showed differential  sensitivity to these  IgG fractions (Fig. 4). 
Anti-urokinase  completely neuralized  the  activity of the  Mr 
52,000 form in CM (lane 2) but had no effect on the activity of 
the other forms (Mr 74,000-100,000). In contrast, the presence 
of antitissue activator IgG (lane 3) blocked the activities of the 
high molecular weight forms but had little detectable effect on 
the activity of the lower molecular weight forms. These results 
were confirmed with CM prepared from cloned BAEs (unpub- 
lished  observation).  Fibrin-agarose  plates  containing nonim- 
mune IgG did not affect the activity of any of the PA forms. 
Sensitivity  of Cellular PAs to Inactivation  by DFP 
The relative sensitivity of the various PA forms to inactiva- 
tion  by  DFP  was  assessed.  CM  was  treated  with  DFP  for 
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activator IgG. Urokinase (0.01 U; lanes  1, 3,  5)  and tissue activator 
{0.01 U; lanes 2, 4, 6) were subjected to analysis by SDS PAGE and 
activity localized on  fibrin-agar gels containing 80 ~g/ml  of either 
nonimmune IgG  (lanes  1 and  2), anti-tissue activator IgG  (lanes 3 
and 4) or anti-urokinase IgG (lanes 5 and 6). The gels were allowed 
to develop for 6 h. 
FIGURE  4  Neutralization of  BAE  PAs  by anti-urokinase  and  anti- 
tissue activator IgG. CM was fractionated by SDS PAGE and analyzed 
on  fibrin-agar indicator gels containing 20 #g/ml  nonimmune  IgG 
(lane 1), 20#g/ml anti-urokinase IgG (lane 2) or 20/~g/ml anti-tissue 
activator IgG  (lane 3). The gels were allowed to develop for 6 h. 
various times, fractionated by SDS  PAGE,  and residual PA 
activity was then localized by fibrin autography (Fig. 5).  Al- 
though the 74,000 form was almost completely inactivated by 
treatment  with  1 mM  DFP  (lanes A2  and  B2),  the  52,000- 
dalton form remained relatively active even after incubation 
with 10 mM DFP (lanes A3 and B3). The 100,000-dalton form 
was apparently refractory to DFP treatment since no change 
in the activity of this form was observed after 2 h  of exposure 
to 10 mM DFP (lane B3). Treatment of CM with 40 mM DFP 
did not decrease the activity of this molecule (not shown). To 
insure that residual PA activity represented a DFP-insensitive 
molecule and was not simply due to hydrolysis  and inactivation 
of the DFP during the incubation period, 0.5  U  of urokinase 
was added to the CM sample that previously had been treated 
with  1 mM DFP for 2 h  (the sample shown in lane A 2). The 
mixture  was  incubated  for  an  additional  30  min  and  then 
analyzed for urokinase activity. The urokinase was completely 
inactivated by this treatment  (lane  C2) even though  cellular 
PA activity was still detected at 3,1r 52,000.  The DFP sensitivity 
of cell  associated PAs was  identical to  their  corresponding 
secreted forms (not shown). 
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FIGURE  5  Inactivation of secreted PAs by DFP. Conditioned media 
(equivalent to 0.5 U  of urokinase activity) was treated with  1 or 10 
mM DFP for 2 h at 37°C. After incubation, the samples were frozen 
in  a dry-ice ethanol  bath, fractionated  by SDS  PAGE  and  residual 
PA  activity determined  on  fibrin-agar gels.  (A)  Lane  1,  untreated 
control; Lane 2, 1 mM DFP; Lane 3, 10 mM DFP, assayed for4 h. (13) 
Same as (A)  but after 8-h incubation. (C)  Lane 1, urokinase (0.5 U); 
Lane 2, urokinase (0.5 U)  was added to the sample treated for 2 h 
with 1 mM DFP (A, Lane 2) and then incubated for an additional 30 
rain. Assay was for 4 h. 
DISCUSSION 
A variety of normal and transformed cells in culture have been 
shown to produce multiple, molecular weight forms of PA (22- 
25). These PAs were found to range in size from Mr 36,000 to 
Mr 100,000  and larger. The lower molecular weight PAs from 
several of these cell lines (Mr  -50,000)  were  neutralized by 
antiurokinase, but the activity of the larger molecular weight 
forms  was  apparently resistant  to  such  treatment.  Although 
this  resistance suggests that  the  larger forms  may be  tissue- 
activator-like PAs, direct immunochemical and functional ev- 
idence for this conclusion is lacking. The relationship of the 
various forms to each other is not at all clear from these studies. 
Our  studies  with  cultured  endothelial cells resolve many  of 
these uncertainties. 
Analysis of cell extracts and  conditioned media from cul- 
tured BAEs by SDS  PAGE revealed the presence of at least 
three  distinct molecules with  PA  activity, and  a  number  of 
others not clearly resolved by this approach (Fig. 1). That these 
activities result from the presence of only two classes of acti- 
vator can be argued from the following observations. First, the 
complex  molecular weight pattern  observed by  SDS  PAGE 
reduced  to  a  rather  simple,  two  component  pattern  upon 
isoelectric focusing (Fig. 2 A). Symmetrical peaks of PA activity 
were detected at pH 8.5 and at pH 7.6.  Subsequent fractiona- 
tion of the focused samples by SDS PAGE (Fig. 2 B) revealed 
that  the  activity  recovered  at  pH  8.5  contained  only  one 
molecular species of activator, that of Mr 52,000.  This form was 
not detected at the lower isoelectric point. The size and charge 
properties of the Mr 52,000 form are similar to those reported 
for urokinase (26).  All of the higher molecular weight forms 
(Mr 74,000-100,000) migrated to one position in the gel, at pH 
7.5. The higher molecular weight, lower pI of these other forms 
is consistent with the properties of tissue-activator-like  PAs (21, 
27).  Second, and in agreement with these conclusions, are the 
antibody neutralization experiments. Only the activity of the 
Mr 52,000 form was blocked by antiurokinase (Fig. 3); it was 
not affected by antitissue activator (Fig. 4). The activity of all 
the  high  molecular  weight  forms  (Mr  74,000-100,000)  was 
neutralized by antitissue activator (Fig. 4) but was not affected 
by anti-urokinase (Fig. 3).  Third, the high molecular weight 
forms behaved as a single class of biochemically similar mole- cules with respect to their interaction with fibrin (Loskutoff 
and  Mussoni,  unpublished  observations). All of these  forms 
not only bound to fibrin, but also appeared to require fibrin 
for their activity. This fibrin cofactor requirement is the pri- 
mary functional distinction between tissue-type and  urinary 
PAs (6).  The Mr 52,000  form resembled urokinase in that it 
showed no association with fibrin. 
Thus,  it is clear from the above considerations that the Mr 
52,000 form is a urokinaselike PA, while the Mr 74,000-100,000 
forms behave in all respects like tissue-type PAs. Whether these 
two classes of PA are actually products of two separate genes 
(22) remains to be determined. Similarly, the exact relationship 
among the multiple forms of tissue-type PA (Mr 74,000--100,- 
000)  remains  unclear.  Although  it  is possible that  they  are 
products  of multiple  genes,  the  fact  that  they  demonstrate 
similar pls,  are  sensitive to  the  same  antisera,  and  interact 
similarly with fibrin, suggests a common origin from a  single 
gene.  The  DFP-inactivation studies  (Fig.  5)  would  seem  to 
suggest a  precursor-product relationship. That is, the relative 
insensitivity to DFP of the Mr 100,000  form is consistent with 
the behavior of a  proenzyme. Like other zymogen activation 
reactions (28),  activation in this case would be expected to be 
a  proteolytic process  resulting  in  the  formation  of a  lower 
molecular weight, DFP-sensitive molecule. The Mr 74,000 form 
has these properties. The relative insensitivity of the unresolved 
activity between Mr 80,000-100,000 suggests that this material 
may represent inactive degradation products of the larger form. 
The ability to detect PA activity at all in DFP-resistant material 
seems at first glance, to be inconsistent with this model. How- 
ever, this activity may arise after treatment with DFP, perhaps 
during SDS PAGE, and may only reflect a small percentage of 
the potential activity of the molecule. Conclusive support for 
these speculations awaits purification of the relevant molecules 
and specific activity determinations. 
It  is  intriguing  that  cells of the  vascular wall  should  be 
associated with both tissue-type (fibrin-dependent) and uroki- 
naselike  (fibrin-independent)  PA  activity.  It  may  be  that 
expression  of  both  activities  is  critical  for  the  role  of the 
endothelium in maintaining vessel patency. On the other hand, 
recent observations indicate that urokinase is a relatively inef- 
fective thrombolytic agent when compared to tissue-type PAs 
(8),  suggesting that  it may be important  for processes other 
than fibrinolysis (29). Rijken et al (4) detected only tissuelike 
PA activity in sections of the vascular wall. This finding differs 
from the results presented here and may reflect species or tissue 
specificity, or changes that  occur in cultured cells. It is also 
possible that the presence of both types of activator reflects a 
heterogeneity of cells in our cultures. If so, it is unlikely that 
such heterogeneity is due to the presence of a subpopulation of 
nonendothelial vascular cells (i.e., smooth muscle cells or fi- 
broblasts)  since  the  morphology  of cultures  maintained  at 
confluency for 2 wk and fed every 3 d, did not change from the 
"cobblestone" appearance of the original cultures. If the other 
ceils were  present,  the  cultures  would  quickly convert  to  a 
multilayered population of elongated cells under these condi- 
tions  (30).  Laug  (14)  recently  observed  multiple  molecular 
weight forms of PA in a cloned isolate of BAEs. We also have 
confirmed our results with six separate clonal isolates, indicat- 
ing  directly that  BAEs produce  both  types of PA.  Because 
BAEs may be phenotypicaUy unstable (31), it is possible that 
the  cultures  consisted of two  subpopulations of endothelial 
cells with one producing only the urokinaselike molecule and 
the other the tissue-type PAs.  Satisfactory resolution of this 
possibility will  depend  upon  development  of techniques  to 
detect both activities in single cells. In any case, it is clear that 
endothelium has the potential to produce both classes of acti- 
vator.  How expression of each is regulated, and  the relative 
importance of each in  in vivo fibrinolysis will await further 
studies. 
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